Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Rea

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Blood Advances|November 10, 2020
Handling challenging questions in the management of chronic myeloid leukemia: when is it safe to stop tyrosine kinase inhibitors?Delphine Rea
Haematologica|December 4, 2025
Prognostic factors in chronic myeloid leukemia: at diagnosis and for treatment-free remissionDelphine Rea
Hematology. American Society of Hematology. Education Program|December 4, 2020
Handling challenging questions in the management of chronic myeloid leukemia: when is it safe to stop tyrosine kinase inhibitors?Delphine Rea
Blood|October 23, 2025
A newcomer in allosteric therapy for Ph+ leukemiasDelphine Rea
Annals of Hematology|March 28, 2015
Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemiaDelphine Rea
British Journal of Haematology|October 20, 2017
How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapyDelphine Rea, François-Xavier Mahon
International Journal of Hematology|July 10, 2017
Treatment-free remission in patients with chronic myeloid leukemiaDelphine Rea, Jean-Michel Cayuela
Leukemia|March 5, 2025
Living, not just surviving, with chronic myeloid leukemia - quality of life to the front of the lineJeffrey H Lipton, Delphine Rea
Current Hematologic Malignancy Reports|November 25, 2019
Towards a Personalized Treatment of Patients with Chronic Myeloid LeukemiaFlorence Rabian, Etienne Lengline, Delphine Rea
Oncotarget|February 14, 2018
What is treatment free remission in chronic myeloid leukemia?Delphine Rea, Gabriel Etienne, François-Xavier Mahon
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Blood Advances|November 10, 2020
Handling challenging questions in the management of chronic myeloid leukemia: when is it safe to stop tyrosine kinase inhibitors?Delphine Rea
Haematologica|December 4, 2025
Prognostic factors in chronic myeloid leukemia: at diagnosis and for treatment-free remissionDelphine Rea
Hematology. American Society of Hematology. Education Program|December 4, 2020
Handling challenging questions in the management of chronic myeloid leukemia: when is it safe to stop tyrosine kinase inhibitors?Delphine Rea
Blood|October 23, 2025
A newcomer in allosteric therapy for Ph+ leukemiasDelphine Rea
Annals of Hematology|March 28, 2015
Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemiaDelphine Rea
British Journal of Haematology|October 20, 2017
How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapyDelphine Rea, François-Xavier Mahon
International Journal of Hematology|July 10, 2017
Treatment-free remission in patients with chronic myeloid leukemiaDelphine Rea, Jean-Michel Cayuela
Leukemia|March 5, 2025
Living, not just surviving, with chronic myeloid leukemia - quality of life to the front of the lineJeffrey H Lipton, Delphine Rea
Current Hematologic Malignancy Reports|November 25, 2019
Towards a Personalized Treatment of Patients with Chronic Myeloid LeukemiaFlorence Rabian, Etienne Lengline, Delphine Rea
Oncotarget|February 14, 2018
What is treatment free remission in chronic myeloid leukemia?Delphine Rea, Gabriel Etienne, François-Xavier Mahon
Pageof 11